Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew Plc    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
11/24/2020 11/25/2020 11/26/2020 11/27/2020 11/30/2020 Date
1423.5(c) 1404.5(c) 1416(c) 1452.5(c) 1460 Last
1 865 907 1 505 694 1 441 787 4 286 455 73 077 Volume
-0.73% -1.33% +0.82% +2.58% +0.52% Change
More quotes
Financials (USD)
Sales 2020 4 694 M - -
Net income 2020 389 M - -
Net Debt 2020 1 633 M - -
P/E ratio 2020 45,4x
Yield 2020 1,50%
Sales 2021 5 303 M - -
Net income 2021 683 M - -
Net Debt 2021 1 245 M - -
P/E ratio 2021 24,7x
Yield 2021 1,99%
Capitalization 16 902 M 16 921 M -
EV / Sales 2020 3,95x
EV / Sales 2021 3,42x
Nbr of Employees 17 500
Free-Float 98,7%
More Financials
Company
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows: - specialized surgery (73.1%): orthopedics (primarily orthopedic implants ; hips, knees and shoulders) and endoscopy (surgery and damaged tissue repair products, visualization products, etc.); - wound care (26.9%): skin grafts for major burns victims,... 
More about the company
Notations Surperformance© of Smith & Nephew Plc
Trading Rating : Investor Rating :
More Ratings
All news about SMITH & NEPHEW PLC
11/23SMITH & NEPHEW : SCOTUS To Decide Constitutionality Of PTAB Judge Appointments
AQ
11/20SMITH & NEPHEW : Investor presentation October - December 2020
PU
11/20SMITH & NEPHEW : What Arthrex Could Mean For The PTAB Going Forward
AQ
11/18SMITH & NEPHEW : New data shows Smith+Nephew's NOVOSTITCH Meniscal Repair System..
AQ
11/13ARTHREX : Who Are You Calling Inferior?
AQ
11/06SMITH & NEPHEW : +Nephew adds patient selection and care-pathway optimization to..
AQ
10/31SMITH & NEPHEW PLC : Monthly statement on outstanding equity shares and voting r..
CO
10/29SMITH & NEPHEW : +Nephew revenue lifted by recovery in elective surgery demand
RE
10/29SMITH & NEPHEW : 3Q Underlying Revenue Improved After Virus Hit
DJ
10/29SMITH & NEPHEW : +Nephew Third Quarter 2020 Trading Report
PU
10/29SMITH & NEPHEW PLC : 3rd quarter results
CO
10/29SMITH & NEPHEW PLC : Press Release
CO
10/28PODCAST : Arthrex v. Smith & Nephew
AQ
10/26WPP appoints former Baidu executive Ya-Qin Zhang to board
RE
10/22MISSING APPOINTMENTS : Supreme Court Grants Certiorari In Arthrex V. Smith & Nep..
AQ
More news
News in other languages on SMITH & NEPHEW PLC
04/30SMITH & NEPHEW PLC : Veröffentlichung des Quartalsumsatzes
04/30SMITH & NEPHEW PLC : publication du chiffre d'affaires trimestriel
02/20SMITH & NEPHEW PLC : prudent vis-à-vis du coronavirus
02/20Les investisseurs renouent avec la prudence face au coronavirus
01/23SMITH & NEPHEW : Eine neu veröffentlichte multizentrische RCT zeigt, dass Smith+..
More news
Analyst Recommendations on SMITH & NEPHEW PLC
More recommendations
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | SN. | GB0009223206 | MarketScreener
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 21,29 $
Last Close Price 19,34 $
Spread / Highest target 38,7%
Spread / Average Target 10,1%
Spread / Lowest Target -31,1%
EPS Revisions
Managers
NameTitle
Roland D. Diggelmann Chief Executive Officer & Non-Executive Director
Roberto Quarta Chairman
Mark Gladwell President-Global Operations & Business Services
Anne-Francoise Nesmes Chief Financial Officer & Executive Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors